Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kiniksa Pharmaceuticals International (KNSA) Tax Provisions (2021 - 2025)

Historic Tax Provisions for Kiniksa Pharmaceuticals International (KNSA) over the last 5 years, with Q3 2025 value amounting to $8.7 million.

  • Kiniksa Pharmaceuticals International's Tax Provisions rose 5881.28% to $8.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.7 million, marking a year-over-year increase of 26593.08%. This contributed to the annual value of $7.0 million for FY2024, which is 12290.8% up from last year.
  • Per Kiniksa Pharmaceuticals International's latest filing, its Tax Provisions stood at $8.7 million for Q3 2025, which was up 5881.28% from $5.0 million recorded in Q2 2025.
  • Kiniksa Pharmaceuticals International's 5-year Tax Provisions high stood at $8.7 million for Q3 2025, and its period low was -$177.4 million during Q3 2022.
  • In the last 5 years, Kiniksa Pharmaceuticals International's Tax Provisions had a median value of $1.9 million in 2022 and averaged -$9.2 million.
  • Within the past 5 years, the most significant YoY rise in Kiniksa Pharmaceuticals International's Tax Provisions was 81666.67% (2022), while the steepest drop was 15020338.98% (2022).
  • Quarter analysis of 5 years shows Kiniksa Pharmaceuticals International's Tax Provisions stood at $279000.0 in 2021, then skyrocketed by 753.05% to $2.4 million in 2022, then crashed by 1057.44% to -$22.8 million in 2023, then skyrocketed by 64.49% to -$8.1 million in 2024, then soared by 207.8% to $8.7 million in 2025.
  • Its Tax Provisions stands at $8.7 million for Q3 2025, versus $5.0 million for Q2 2025 and $7.0 million for Q1 2025.